Skip to main content
Premium Trial:

Request an Annual Quote

Pine Biotech Raises $1M

NEW YORK (GenomeWeb) – Pine Biotech announced today that it has raised $1,025,000 million in angel seed funding.

The New Orleans-based startup, which was incorporated in 2014, is commercializing a biomedical data analysis and machine learning platform, in collaboration with the Tauber Bioinformatics Research Center and the University of Haifa. The money Pine Biotech has raised will be used to develop and commercialize the platform, which is designed for the analysis of large genomic, transcriptomic, proteomic, structural, and phenotypic datasets.

The machine learning platform utilizes algorithms developed over years of research and trained in many academic projects, the firm added. It also includes a machine learning toolkit and interactive visualization.

"By enabling researchers and clinicians to extract real insight from omics data, we hope that new and more effective approaches to diagnostics and therapeutics will be developed," Pine Biotech CEO Elia Brodsky said in a statement.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.